Synthesis of EPA-enriched medium- and long-chain triacylglycerol by lipase-catalyzed transesterification: a novel strategy for clinical nutrition intervention.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the science of food and agriculture"
DOI: 10.1002/jsfa.12542
Abstract: BACKGROUND Eicosapentaenoic acid (EPA) has been recognized as a promising nutrient to improve the therapeutic efficacy of cancer patients. Nevertheless, there are certain limitations to the application of EPA due to its structural characteristics. To… read more here.
Keywords: epa; medium; mlct; epa enriched ... See more keywords
EPA-enriched phosphoethanolamine plasmalogens alleviated atherosclerosis by remodeling gut microbiota to regulate bile acid metabolism in LDLR -/- mice.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of agricultural and food chemistry"
DOI: 10.1021/acs.jafc.9b08296
Abstract: EPA-enriched phosphoethanolamine plasmalogens (EPA-PlsEtns) might be retained in intestine rich in gut microbiota for a long time after treatment. It reminded us that EPA-PlsEtns might affect intestinal microbiota composition and its metabolites, which have been… read more here.
Keywords: microbiota; enriched phosphoethanolamine; epa plsetns; epa enriched ... See more keywords
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Nutrition and cancer"
DOI: 10.1080/01635581.2020.1871495
Abstract: BACKGROUND Pancreatic cancer is often associated with cachexia. It had been reported that eicosapentaenoic acid (EPA) improve cachexia. This study aimed to evaluate the efficacy and safety of gemcitabine with an EPA-enriched oral supplement in… read more here.
Keywords: gemcitabine; enriched oral; pancreatic cancer; epa enriched ... See more keywords
EPA-Enriched Phospholipids Alleviate Renal Interstitial Fibrosis in Spontaneously Hypertensive Rats by Regulating TGF-β Signaling Pathways
Sign Up to like & getrecommendations! Published in 2022 at "Marine Drugs"
DOI: 10.3390/md20020152
Abstract: Hypertensive nephropathy is a chronic kidney disease caused by hypertension. Eicosapentaenoic acid (EPA) has been reported to possess an antihypertensive effect, and our previous study suggested that EPA-enriched phospholipid (EPA-PL) had more significant bioactivities compared… read more here.
Keywords: epa; kidney; epa enriched; fibrosis ... See more keywords